Shanghai Pharmaceuticals Holding Co., Ltd (SHA: 601607)
China flag China · Delayed Price · Currency is CNY
20.91
-0.23 (-1.09%)
Nov 13, 2024, 3:00 PM CST

Shanghai Pharmaceuticals Holding Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Cash & Equivalents
33,82330,51827,40122,39022,35418,200
Upgrade
Trading Asset Securities
8,56310,1529,614---
Upgrade
Cash & Short-Term Investments
42,38540,67037,01522,39022,35418,200
Upgrade
Cash Growth
4.22%9.87%65.32%0.16%22.83%-5.95%
Upgrade
Accounts Receivable
86,05477,16370,18761,00655,52249,801
Upgrade
Other Receivables
3,2402,3731,9571,7861,3431,518
Upgrade
Receivables
89,29479,53672,14462,79156,86551,319
Upgrade
Inventory
37,57636,62334,46027,10424,08824,877
Upgrade
Other Current Assets
4,5325,6055,8944,2094,2553,695
Upgrade
Total Current Assets
173,788162,434149,513116,494107,56398,092
Upgrade
Property, Plant & Equipment
18,72618,30216,55015,79314,62613,128
Upgrade
Long-Term Investments
10,38110,60311,47710,8367,6635,432
Upgrade
Goodwill
11,40811,39311,33611,23911,34210,790
Upgrade
Other Intangible Assets
5,7546,0706,2636,0495,1953,930
Upgrade
Long-Term Deferred Tax Assets
1,8051,7171,5351,3681,3591,223
Upgrade
Long-Term Deferred Charges
220.2310.51342.61259.23639.15606.39
Upgrade
Other Long-Term Assets
1,6601,1431,1191,397797.643,825
Upgrade
Total Assets
223,741211,973198,135163,436149,186137,026
Upgrade
Accounts Payable
61,68854,63251,56641,99537,79236,872
Upgrade
Accrued Expenses
1,59110,6389,5747,9856,8165,405
Upgrade
Short-Term Debt
45,01741,61233,81131,59225,15823,139
Upgrade
Current Portion of Long-Term Debt
1,9272,3662,64933.448,311624.86
Upgrade
Current Portion of Leases
-596.67580.68545.04574.57560.87
Upgrade
Current Income Taxes Payable
952.11809.8781.36721.16682.45716.99
Upgrade
Current Unearned Revenue
1,4421,9712,2431,3111,3111,534
Upgrade
Other Current Liabilities
16,9169,7479,4877,6427,4885,755
Upgrade
Total Current Liabilities
129,532122,372110,69191,82488,13374,608
Upgrade
Long-Term Debt
7,6905,7866,2607,1581,1849,134
Upgrade
Long-Term Leases
1,6191,5501,3021,4341,5011,156
Upgrade
Long-Term Unearned Revenue
589.68633.48534.582,3492,2241,279
Upgrade
Long-Term Deferred Tax Liabilities
876.711,0161,049998.77832.38809.6
Upgrade
Other Long-Term Liabilities
251.34250.14257.26566.09570.39654.6
Upgrade
Total Liabilities
140,584131,646120,132104,36994,44587,640
Upgrade
Common Stock
3,7053,7033,6982,8422,8422,842
Upgrade
Additional Paid-In Capital
-29,18829,09816,07115,89815,721
Upgrade
Retained Earnings
38,36836,12934,63930,59126,88023,639
Upgrade
Comprehensive Income & Other
28,793-496.09-371.32-144.39-265.41-542.23
Upgrade
Total Common Equity
70,86668,52467,06349,35945,35541,659
Upgrade
Minority Interest
12,29211,80210,9399,7079,3867,727
Upgrade
Shareholders' Equity
83,15880,32678,00259,06654,74149,386
Upgrade
Total Liabilities & Equity
223,741211,973198,135163,436149,186137,026
Upgrade
Total Debt
56,25351,91144,60240,76236,72834,614
Upgrade
Net Cash (Debt)
-13,867-11,241-7,587-18,372-14,374-16,415
Upgrade
Net Cash Per Share
-3.72-3.04-2.18-6.46-5.06-5.78
Upgrade
Filing Date Shares Outstanding
3,7053,7033,6982,8422,8422,842
Upgrade
Total Common Shares Outstanding
3,7053,7033,6982,8422,8422,842
Upgrade
Working Capital
44,25640,06238,82224,67019,43023,484
Upgrade
Book Value Per Share
19.1318.5018.1417.3715.9614.66
Upgrade
Tangible Book Value
53,70451,06149,46432,07128,81726,939
Upgrade
Tangible Book Value Per Share
14.5013.7913.3811.2810.149.48
Upgrade
Buildings
-11,46010,9419,6989,3518,480
Upgrade
Machinery
-10,0359,0548,2037,7436,799
Upgrade
Construction In Progress
-3,5702,7772,9141,7371,650
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.